| |
| |
|
| Insider
Information: |
Berger Harvey J MD |
| Relationship: |
Chairman & CEO, Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,732,111 |
|
|
Indirect Shares
|
2,604,336 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
4,336,447 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
Chairman & CEO, Director |
2015-12-31 |
1,732,111 |
2015-12-31 |
2,604,336 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
99 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-05-14 |
4 |
AS |
$18.01 |
$900,295 |
D/D |
(50,000) |
1,553,935 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-05-14 |
4 |
AS |
$18.00 |
$48,600 |
I/I |
(2,700) |
19,357 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-05-15 |
4 |
AS |
$18.22 |
$675,970 |
D/D |
(37,098) |
1,516,837 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-05-15 |
4 |
AS |
$18.14 |
$48,983 |
I/I |
(2,700) |
16,657 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-06-19 |
4 |
AS |
$18.00 |
$104,415 |
D/D |
(5,800) |
1,511,037 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-06-19 |
4 |
AS |
$18.00 |
$97,208 |
I/I |
(5,400) |
11,257 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-07-16 |
4 |
AS |
$20.97 |
$56,623 |
I/I |
(2,700) |
8,557 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-07-16 |
4 |
AS |
$19.91 |
$2,866,478 |
D/D |
(144,000) |
1,405,861 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-07-17 |
4 |
AS |
$19.60 |
$52,912 |
I/I |
(2,700) |
5,857 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-07-17 |
4 |
AS |
$19.61 |
$980,705 |
D/D |
(50,000) |
1,355,861 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-08-13 |
4 |
AS |
$18.36 |
$49,570 |
I/I |
(2,700) |
3,157 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-08-13 |
4 |
AS |
$18.11 |
$905,555 |
D/D |
(50,000) |
1,305,661 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-08-14 |
4 |
AS |
$18.51 |
$1,164,335 |
D/D |
(62,902) |
1,242,759 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-08-14 |
4 |
AS |
$18.37 |
$57,999 |
I/I |
(3,157) |
0 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2009-08-04 |
4 |
B |
$1.75 |
$3,000,001 |
I/I |
1,714,286 |
1,714,286 |
2.66 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
officerTitle |
• • – |
2005-10-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(780,356) |
0 |
|
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2012-03-22 |
4 |
D |
$15.68 |
$639,368 |
D/D |
(40,776) |
2,146,676 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2012-06-13 |
4 |
D |
$16.79 |
$99,984 |
D/D |
(5,955) |
2,189,683 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2012-12-18 |
4 |
D |
$20.18 |
$526,577 |
D/D |
(26,094) |
2,226,089 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-03-20 |
4 |
D |
$20.45 |
$328,529 |
D/D |
(16,065) |
1,694,024 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-03-22 |
4 |
D |
$19.38 |
$894,348 |
D/D |
(46,148) |
1,745,543 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-04-01 |
4 |
D |
$18.30 |
$360,290 |
D/D |
(19,688) |
1,767,521 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-07-15 |
4 |
D |
$20.98 |
$729,600 |
D/D |
(34,776) |
1,549,861 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-12-18 |
4 |
D |
$4.98 |
$146,910 |
D/D |
(29,500) |
1,050,759 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$95,913 |
D/D |
(11,711) |
1,075,048 |
0 |
- |
|
99 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
